Biomerieux SA
PAR:BIM

Watchlist Manager

Biomerieux SA

PAR:BIM

Watchlist

Dividends

Price: 101.8 EUR 0.3%

Market Cap: 12B EUR

Have any thoughts about
Biomerieux SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 101.8 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BIM Alert

Biomerieux SA

101.8

+0.3 (+0.3%)

52 Week Range	88.75 110.3
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Biomerieux SA

What unique competitive advantages
does Biomerieux SA hold over its rivals?

What risks and challenges
does Biomerieux SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Biomerieux SA.

What unique competitive advantages
does Biomerieux SA hold over its rivals?

What risks and challenges
does Biomerieux SA face in the near future?

Has there been any significant insider trading activity
in Biomerieux SA recently?

Summarize the latest earnings call
of Biomerieux SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biomerieux SA.

Provide P/S
for Biomerieux SA.

Provide P/E
for Biomerieux SA.

Provide P/OCF
for Biomerieux SA.

Provide P/FCFE
for Biomerieux SA.

Provide P/B
for Biomerieux SA.

Provide EV/S
for Biomerieux SA.

Provide EV/GP
for Biomerieux SA.

Provide EV/EBITDA
for Biomerieux SA.

Provide EV/EBIT
for Biomerieux SA.

Provide EV/OCF
for Biomerieux SA.

Provide EV/FCFF
for Biomerieux SA.

Provide EV/IC
for Biomerieux SA.

Show me price targets
for Biomerieux SA made by professional analysts.

What are the Revenue projections
for Biomerieux SA?

How accurate were the past Revenue estimates
for Biomerieux SA?

What are the Net Income projections
for Biomerieux SA?

How accurate were the past Net Income estimates
for Biomerieux SA?

What are the EPS projections
for Biomerieux SA?

How accurate were the past EPS estimates
for Biomerieux SA?

What are the EBIT projections
for Biomerieux SA?

How accurate were the past EBIT estimates
for Biomerieux SA?

Compare the revenue forecasts
for Biomerieux SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biomerieux SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biomerieux SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biomerieux SA compared to its peers.

Compare the P/E ratios
of Biomerieux SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Biomerieux SA with its peers.

Analyze the financial leverage
of Biomerieux SA compared to its main competitors.

Show all profitability ratios
for Biomerieux SA.

Provide ROE
for Biomerieux SA.

Provide ROA
for Biomerieux SA.

Provide ROIC
for Biomerieux SA.

Provide ROCE
for Biomerieux SA.

Provide Gross Margin
for Biomerieux SA.

Provide Operating Margin
for Biomerieux SA.

Provide Net Margin
for Biomerieux SA.

Provide FCF Margin
for Biomerieux SA.

Show all solvency ratios
for Biomerieux SA.

Provide D/E Ratio
for Biomerieux SA.

Provide D/A Ratio
for Biomerieux SA.

Provide Interest Coverage Ratio
for Biomerieux SA.

Provide Altman Z-Score Ratio
for Biomerieux SA.

Provide Quick Ratio
for Biomerieux SA.

Provide Current Ratio
for Biomerieux SA.

Provide Cash Ratio
for Biomerieux SA.

What is the historical Revenue growth
over the last 5 years for Biomerieux SA?

What is the historical Net Income growth
over the last 5 years for Biomerieux SA?

What is the current Free Cash Flow
of Biomerieux SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biomerieux SA.

EV/EBITDA
Enterprise Value to EBITDA

16.1

Current

16.5

Median

12.7

Industry

Lower than median

Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

16.1

Enterprise Value

12.1B EUR

EBITDA

753.4m EUR

All Countries

Forward Multiples

		Market Cap	EV/EBITDA
FR	Biomerieux SA PAR:BIM	12B EUR	16.1
US	Abbott Laboratories NYSE:ABT	199.5B USD	20.1
US	Intuitive Surgical Inc NASDAQ:ISRG	190.6B USD	72.6
US	Stryker Corp NYSE:SYK	140.3B USD	25.4
US	Boston Scientific Corp NYSE:BSX	133.7B USD	34.2
IE	Medtronic PLC NYSE:MDT	104.5B USD	13.6
US	Becton Dickinson and Co NYSE:BDX	65.8B USD	15.8
DE	Siemens Healthineers AG XETRA:SHL	58.1B EUR	17.7
US	Edwards Lifesciences Corp NYSE:EW	44.3B USD	23.7
CN	Shenzhen Mindray Bio-Medical Electronics Co Ltd SZSE:300760	308.3B CNY	21.6
US	GE Healthcare Technologies Inc NASDAQ:GEHC	36.4B USD	13.6

			EBITDA Growth	EV/EBITDA to Growth
FR	Biomerieux SA PAR:BIM	Average EV/EBITDA: 24.9 16.1	75%	0.2
US	Abbott Laboratories NYSE:ABT	20.1	32%	0.6
US	Intuitive Surgical Inc NASDAQ:ISRG	72.6	112%	0.6
US	Stryker Corp NYSE:SYK	25.4	42%	0.6
US	Boston Scientific Corp NYSE:BSX	34.2	76%	0.5
IE	Medtronic PLC NYSE:MDT	13.6	29%	0.5
US	Becton Dickinson and Co NYSE:BDX	15.8	35%	0.4
DE	Siemens Healthineers AG XETRA:SHL	17.7	53%	0.3
US	Edwards Lifesciences Corp NYSE:EW	23.7	10%	2.4
CN	Shenzhen Mindray Bio-Medical Electronics Co Ltd SZSE:300760	21.6	70%	0.3
US	GE Healthcare Technologies Inc NASDAQ:GEHC	13.6	41%	0.3

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

13.2

2-Years Forward

EV/EBITDA

11.9

3-Years Forward

EV/EBITDA

10.5

	Franklin Covey Co NYSE:FC	36.775 USD -0.26%
	Mohawk Industries Inc NYSE:MHK	119.22 USD -0.81%
	Ardmore Shipping Corp NYSE:ASC	11.81 USD -2.56%
	ASGN Inc NYSE:ASGN	83.78 USD -0.44%
	Skyworks Solutions Inc NASDAQ:SWKS	90.9999 USD 0.72%
	Weatherford International PLC NASDAQ:WFRD	67.69 USD -0.56%

	Johnson & Johnson NYSE:JNJ	145.86 USD 0.01%
	Bank of America Corp NYSE:BAC	44.3 USD -0.18%
	Mastercard Inc NYSE:MA	534.51 USD -0.22%
	Salesforce Inc NYSE:CRM	342.855 USD -0.46%
	Abbvie Inc NYSE:ABBV	179.58 USD -0.23%
	Home Depot Inc NYSE:HD	392.33 USD -0.92%

	Arista Networks Inc NYSE:ANET	114.29 USD -0.31%
	Visa Inc NYSE:V	319.825 USD -0.26%
	Texas Pacific Land Corp NYSE:TPL	1 154.91 USD -0.54%
	KLA Corp NASDAQ:KLAC	650.13 USD -0.06%
	Manhattan Associates Inc NASDAQ:MANH	280.205 USD -0.73%
	Pinduoduo Inc NASDAQ:PDD	99.175 USD -0.55%

	Salesforce Inc NYSE:CRM	342.855 USD -0.46%
	Accenture PLC NYSE:ACN	361.19 USD -0.12%
	ServiceNow Inc NYSE:NOW	1 097.66 USD -0.71%
	EOG Resources Inc NYSE:EOG	120.88 USD 0.04%
	Copart Inc NASDAQ:CPRT	58.96 USD -0.25%
	Applied Materials Inc NASDAQ:AMAT	168.19 USD -0.11%

Biomerieux SA
PAR:BIM

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Biomerieux SA PAR:BIM

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Biomerieux SA
PAR:BIM

EV/EBITDA
Enterprise Value to EBITDA